secwatch.observer — SEC 8-K summary
======================================

Issuer:     Keen Vision Acquisition Corp. (KVAC)
CIK:        0001889983
Form:       8-K
Filed at:   2026-03-02T23:59:59+00:00
Accession:  0001213900-26-022404
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Keen Vision Acquisition enters binding LOI for $100M merger with Novoheart
--------------------------------------------------------------------------

- LOI replaces prior Sept 2024 Merger Agreement, which was terminated via mutual release.
- Agreed enterprise valuation of Novoheart at $100M; required closing liquidity ≥$10M.
- Cash expense caps: Parent $700K, NVH $1.3M; PIPE fundraising must close within 9 months.
- Parties to negotiate replacement merger agreement by April 10, 2026; conditions consistent with prior agreement.
- Medera China subsidiaries excluded from the business combination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1889983/000121390026022404/0001213900-26-022404-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1889983/000121390026022404/ea0279210-8k_keen.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-022404

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer